Journal of Neuro-Oncology

, Volume 113, Issue 2, pp 341–342 | Cite as

Unclear standard of care for pediatric high grade glioma patients

Letter to the Editor


Bevacizumab Temozolomide Vorinostat High Grade Glioma Patient Pediatric High Grade Glioma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Conflict of interest

  The authors declare no conflicts of interest.


  1. 1.
    Finlay JL et al (1995) Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen Childrens Cancer Group. J Clin Oncol 13(1):112–123PubMedGoogle Scholar
  2. 2.
    Cohen KJ et al (2011) Temozolomide in the treatment of high-grade gliomas in children: a report from the Children’s Oncology Group. Neuro Oncol 13(3):317–323PubMedCrossRefGoogle Scholar
  3. 3.
    Sposto R et al (1989) The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. J Neurooncol 7(2):165–177PubMedCrossRefGoogle Scholar
  4. 4.
    Stupp R et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Pediatric Neuro-OncologyAnn and Robert H. Lurie Children’s Hospital of ChicagoChicagoUSA
  2. 2.Pediatric Oncology BranchNational Cancer InstituteBethesdaUSA

Personalised recommendations